Skip to main content
. Author manuscript; available in PMC: 2018 Nov 21.
Published in final edited form as: Hypertension. 2018 Nov;72(5):1151–1159. doi: 10.1161/HYPERTENSIONAHA.118.11176

Figure 5.

Figure 5.

Influences of klotho protein supplementation on renal p-Akt (phosphorylated Akt) abundance (A) and renal p-mTOR (phosphorylated mTOR, mammalian target of rapamycin) abundance (B). *Significant difference between the 2 groups. C indicates control group; and K, klotho group (n=6 for each).